(Q33750992)

29 July 2017

Clinical trial of clarithromycin for lepromatous leprosy (English)

1 reference

29 July 2017

0 references

1 reference

1 reference

G P Chan

1

1 reference

29 July 2017

B Y Garcia-Ignacio

2

1 reference

29 July 2017

V E Chavez

3

1 reference

29 July 2017

J B Livelo

4

1 reference

29 July 2017

C L Jimenez

5

1 reference

29 July 2017

M L Parrilla

6

1 reference

29 July 2017

S G Franzblau

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

38

1 reference

29 July 2017

515-517

1 reference

29 July 2017

3

1 reference

Clinical trial of sparfloxacin for lepromatous leprosy

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

In vitro and in vivo activities of macrolides against Mycobacterium leprae

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

A clinical trial of minocycline in lepromatous leprosy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284490

Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8203847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8203847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8203847

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.38.3.515

1 reference

29 July 2017

1 reference

29 July 2017

1 reference